Home NDC 71894-200 ITVISMA
Product NDC 71894-200
11-digit product format 718940200
Labeler code 71894
Product ID 71894-200_68c25df1-ad2d-4bb0-8e19-e9a58b868d13
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name onasemnogene abeparvovec-brve
Dosage form INJECTION, SUSPENSION
Route INTRATHECAL
Labeler Novartis Innovative Technologies Inc.
Application BLA125856
Marketing category BLA
Marketing start 2025-11-24
Substance ONASEMNOGENE ABEPARVOVEC
Active strength 40000000000000 [arb'U]/mL
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base ITVISMA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ONASEMNOGENE ABEPARVOVEC 40000000000000 [arb'U]/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination MLU3LU3EVV Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2727307 Internal RxNorm lookup 2727314 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71894-200-01 ITVISMA 3 mL in 1 VIAL, SINGLE-DOSE INJECTION, SUSPENSION 3 1 71894-200-02 ITVISMA 1 in 1 CARTON INJECTION, SUSPENSION 1 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ITVISMA ONASEMNOGENE ABEPARVOVEC-BRVE Novartis Innovative Technologies Inc. ab2e1c6c-4f95-4243-9296-1734e0a30591 2026-06-16 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA125856 ndc (product): 71894-200
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125856 ITVISMA onasemnogene abeparvovec-brve 351(a) Rx 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 71894-200-01 71894020001 3 mL in 1 VIAL, SINGLE-DOSE 3 ml Historical 71894-200-02 71894020002 1 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1 VIAL, SINGLE-DOSE (71894-200-01) 2025-11-24 No No Current